Joining the ruling party is only a partial solution to the country’s problems. Apart from personal consideration, there must be enough justification for ...

Mario Tama / Getty Images Shares of Intra-Cellular Therapies jumped Monday morning after Johnson & Johnson announced plans to buy the biopharmaceutical company. Intra-Cellular shareholders will ...

The drug brought in $175 million in last year’s third quarter as total prescriptions increased 38%. Intra-Cellular said last fall it was expanding its sales force to target growth opportunities with ...

Persistent Link: https://ieeexplore.ieee.org/servlet/opac?punumber=10723154 ...

BHUBANESWAR: The state government on Thursday launched the transformative umbrella scheme, ‘Bikashita Gaon, Bikashita Odisha’ with a provision of Rs 5,000 crore ...

An Intra-University Transfer (IUT) allows current undergraduate students to change, add, or drop a major and degree program involving two different colleges/schools/programs within CU Boulder. The ...

Johnson & Johnson has opened the J.P. Morgan Healthcare Conference with a bang, buying out Intra-Cellular Therapies for $14.6 billion. At $132 per share, J&J paid a 39% premium on Friday’s ...

Intra-Cellular Therapies ITCI signed a definitive agreement with pharma bigwig Johnson & Johnson JNJ. Per the terms, the pharma giant will acquire all outstanding shares of ITCI for $132 per share ...